Nicolas Chomont mainly focuses on Immunology, Virology, Viral load, Antiretroviral therapy and Virus. The Immunology study combines topics in areas such as Peripheral blood mononuclear cell and Acquired immunodeficiency syndrome. His study in Virology is interdisciplinary in nature, drawing from both T cell, Immune system and Transcription.
His Viral load research is multidisciplinary, incorporating perspectives in Pharmacology, In vivo and Emtricitabine. In general Antiretroviral therapy, his work in Treatment interruption and Acute HIV infection is often linked to Latency linking many areas of study. His work in Virus covers topics such as Antibody which are related to areas like Transcytosis.
Nicolas Chomont mostly deals with Immunology, Virology, Viral load, Virus and T cell. Nicolas Chomont interconnects Peripheral blood mononuclear cell and Antiretroviral therapy in the investigation of issues within Immunology. His research investigates the link between Virology and topics such as RNA that cross with problems in Provirus.
His research in Viral load intersects with topics in Cell, Internal medicine, Raltegravir and Emtricitabine. His Virus research is multidisciplinary, incorporating elements of Cell culture, Acquired immunodeficiency syndrome and Polymerase chain reaction. His T cell research includes elements of Virus latency and Cell biology.
His primary scientific interests are in Virology, Immunology, Antiretroviral therapy, Immune system and Viral load. His Virology study incorporates themes from T cell, Cell and DNA. Nicolas Chomont studies Immunology, namely Inflammation.
Placebo is closely connected to Clinical trial in his research, which is encompassed under the umbrella topic of Antiretroviral therapy. Nicolas Chomont has included themes like Bronchoalveolar lavage and Lung in his Immune system study. His Viral load research is multidisciplinary, incorporating perspectives in Internal medicine and Quality of life.
Nicolas Chomont spends much of his time researching Immunology, Antiretroviral therapy, Viral load, Virology and Phenotype. In general Immunology study, his work on Antibody often relates to the realm of Persistence, thereby connecting several areas of interest. His study in the fields of Viral rebound under the domain of Antiretroviral therapy overlaps with other disciplines such as Extramural.
The Viral load study combines topics in areas such as Internal medicine, Tolerability and Flow cytometry. His Virology research incorporates themes from T cell, Subgenomic mRNA and Phylogenetic tree. Nicolas Chomont interconnects Cell, Function, Distribution and Antigen in the investigation of issues within Phenotype.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction
Lydie Trautmann;Loury Janbazian;Loury Janbazian;Nicolas Chomont;Elias A. Said.
Nature Medicine (2006)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont;Mohamed El-Far;Petronela Ancuta;Lydie Trautmann.
Nature Medicine (2009)
Towards an HIV cure: a global scientific strategy
Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane.
Nature Reviews Immunology (2012)
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
Ole S. Søgaard;Mette E. Graversen;Steffen Leth;Rikke Olesen.
PLOS Pathogens (2015)
Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.
Julian H. Elliott;Fiona Wightman;Ajantha Solomon;Khader Ghneim.
PLOS Pathogens (2014)
Immune activation and HIV persistence: implications for curative approaches to HIV infection
Nichole R. Klatt;Nicolas Chomont;Daniel C. Douek;Steven G. Deeks.
Immunological Reviews (2013)
HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals
Didier Trono;Carine Van Lint;Christine Rouzioux;Eric Verdin.
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M. Lynch;Eli Boritz;Emily E. Coates;Adam DeZure.
Science Translational Medicine (2015)
Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection.
Jintanat Ananworanich;Alexandra Schuetz;Claire Vandergeeten;Irini Sereti.
PLOS ONE (2012)
Peripheral Blood CCR4 + CCR6 + and CXCR3 + CCR6 + CD4 + T Cells Are Highly Permissive to HIV-1 Infection
Annie Gosselin;Patricia Monteiro;Nicolas Chomont;Felipe Diaz-Griffero.
Journal of Immunology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: